<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04315168</url>
  </required_header>
  <id_info>
    <org_study_id>FRED-EPI</org_study_id>
    <nct_id>NCT04315168</nct_id>
  </id_info>
  <brief_title>FRED and FRED JR Devices for Intracranial Aneurysm Treatment</brief_title>
  <official_title>Evaluation of Safety and Efficacy of the FRED and FRED JR Devices for Intracranial Aneurysm Treatment</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Microvention-Terumo, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Microvention-Terumo, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A French, multicenter, prospective, observational, &quot;real-world&quot; assessment of the safety and
      efficacy of FRED and FRED Jr devices in the treatment of intracranial aneurysms
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Post Market Clinical Follow-up. Multicenter observational study. Treatment and follow-up far
      at least 12 months as per standard of care.

      Sample Size: 138 patients.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">May 1, 2020</start_date>
  <completion_date type="Anticipated">April 1, 2024</completion_date>
  <primary_completion_date type="Anticipated">March 1, 2023</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>12 Months</target_duration>
  <primary_outcome>
    <measure>Mortality Rate</measure>
    <time_frame>1 year</time_frame>
    <description>Percentage of patients with neurological death</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Morbidity Rate</measure>
    <time_frame>1 year</time_frame>
    <description>Percentage of patients with major ipsilateral stroke</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>modified Rankin Score</measure>
    <time_frame>1 year</time_frame>
    <description>worsening mRS (scale from 0 to 6 : 0= No symptom, 6= Death)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Complete aneurysm occlusion rate</measure>
    <time_frame>1 year</time_frame>
    <description>Measured by the Raymond Scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Retreatment Rate</measure>
    <time_frame>1 year</time_frame>
    <description>Rate and description of aneurysm retreated or planned for retreatment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient description</measure>
    <time_frame>1 year</time_frame>
    <description>Description of the population of patients treated with FRED and FRED JR in France</description>
  </secondary_outcome>
  <enrollment type="Anticipated">138</enrollment>
  <condition>Intracranial Aneurysm</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>FRED and FRED JR</intervention_name>
    <description>Intracranial aneurysm treatment</description>
    <other_name>Flow Re-Direction Endoluminal Device</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patient with an intracranial aneurysm treated with the FRED or FRED JR Device
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient with an intracranial aneurysm for which an endovascular treatment is indicated
             with the device FRED or FRED JR

          -  Patient or patient's legally authorized representative has been informed about the
             study and does not oppose the collection of his/her personal data

        Exclusion Criteria:

          -  None
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Laurent Pierot, Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>HÃ´pital Maison Blanche, Reims, France</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Laurence Bousquet</last_name>
    <phone>+33 1 39 21 52 20</phone>
    <email>laurence.bousquet@microvention.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Patricia Boyer</last_name>
    <phone>+33 1 86 90 28 25</phone>
    <email>patricia.boyer@microvention.com</email>
  </overall_contact_backup>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>March 17, 2020</study_first_submitted>
  <study_first_submitted_qc>March 17, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">March 19, 2020</study_first_posted>
  <last_update_submitted>March 19, 2020</last_update_submitted>
  <last_update_submitted_qc>March 19, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 23, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>aneurysm</keyword>
  <keyword>endovascular</keyword>
  <keyword>flow-diverter</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Intracranial Aneurysm</mesh_term>
    <mesh_term>Aneurysm</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

